Kunz, I: SR141716 (rimonabant) an inverse cannabinoid receptor type I agonist does not increase oxygen consumption and motility in post-absorptive mice lacking CB1 (CB1) : Proccedings of Satellite Meeting of the 13th European Congress on Obesity. Indirect calorimetry in rodent models: Application to studies of the metabolic syndrome. Prague, May 29-30, 2004 [abstract]